On June 25, Xylem rose 5.07% in regular trading, trading at $117.69/share, with turnover of approximately $98.86 million. The rally was driven by Jefferies upgrading the stock from Hold to Buy while raising its price target from $130 to $140.

According to FactSet data, Xylem currently carries an average analyst rating of Overweight with a consensus mean price target of $152.94, implying approximately 30% upside from current levels. The Jefferies upgrade marks a notable shift in sentiment, as the stock had previously seen several target price reductions earlier this year — JPMorgan lowered its target to $140 from $160 in late April, Argus cut to $125 from $150 in May, and UBS downgraded the stock to Neutral in April with a $132 target. Despite these headwinds, the broader analyst community has maintained a constructive stance on Xylem, with firms including Citigroup, Stifel, and RBC Capital retaining positive ratings.

Within the Industrial Machinery sector, peer stocks also posted gains on the session, with Ingersoll Rand up 4.23%, Parker Hannifin up 2.83%, Otis Worldwide up 2.55%, Illinois Tool up 2.33%, and Pentair up 2.19%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)